Recombination and population mosaic of a multifunctional viral gene, adeno-associated virus cap

PLoS ONE

Volumn 3, Issue 2, 2008, Pages

  Takeuchi, Yasuhiro ^a   Myers, Richard ^a,b   Danos, Olivier ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; VIRUS PROTEIN; CAPSID PROTEIN;

ADENO ASSOCIATED VIRUS; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE IDENTIFICATION; GENE SEQUENCE; HOMOLOGOUS RECOMBINATION; MOSAICISM; NONHUMAN; PHYLOGENETIC TREE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; VIRUS CORE; VIRUS GENE; GENETIC RECOMBINATION; GENETICS; PHYLOGENY; VIRUS CAPSID;

ADENO-ASSOCIATED VIRUS; MIRIDAE;

CAPSID; CAPSID PROTEINS; DEPENDOVIRUS; GENES, VIRAL; PHYLOGENY; RECOMBINATION, GENETIC; VIRAL STRUCTURAL PROTEINS;

EID: 45449097258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001634     Document Type: Article

References (27)

1. Hueffer K, Parrish CR (2003) Parvovirus host range, cell tropism and evolution. Current Opinion in Microbiology 6: 392.
2. Shackelton LA, Parrish CR, Truyen U, Holmes EC (2005) High rate of viral evolution associated with the emergence of carnivore parvovirus. PNAS 102: 379-384.
3. Wu Z, Asokan A, Samulski RJ (2006) Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy. Molecular Therapy 14: 316-327.
4. Xie Q, Bu W, Rhatia S, Hare J, Somasundaram T, et al. (2002) The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. PNAS 99: 10405-10410.
5. Grieger JC, Johnson JS, Curda-Whitaker B, Agbandje-McKenna M, Samulski RJ (2007) Surface-Exposed Adeno-Associated Virus Vp1-NLS Capsid Fusion Protein Rescues Infectivity of Noninfectious Wild-Type Vp2/Vp3 and Vp3-Only Capsids but Not That of Fivefold Pore Mutant Virions. J Virol 81: 7833-7843.
6. Kronenberg S, Bottcher B, von der Lieth CW, Bleker S, Kleinschmidt JA (2005) A Conformational Change in the Adeno-Associated Virus Type 2 Capsid Leads to the Exposure of Hidden VP1 N Termini. J Virol 79: 5296-5303.
7. Sonntag F, Bleker S, Leuchs B, Fischer R, Kleinschmidt JA (2006) Adeno-Associated Virus Type 2 Capsids with Externalized VP1/VP2 Trafficking Domains Are Generated prior to Passage through the Cytoplasm and Are Maintained until Uncoating Occurs in the Nucleus. J Virol 80: 110440-11054.
8. Grieger JC, Snowdy S, Samulski RJ (2006) Separate Basic Region Motifs within the Adeno-Associated Virus Capsid Proteins Are Essential for Infectivity and Assembly. J Virol 80: 5199-5210.
9. Zadori Z, Szelei J, Lacoste M-C, Li Y, Gariepy S, et al. (2001) A Viral Phospholipase A2 Is Required for Parvovirus Infectivity. Developmental Cell 1: 291-302.
10. Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, et al. (2004) Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues. J Virol 78: 6381-6388.
11. Chen C-L, Jensen RL, Schnepp BC, Connell MJ, Shell R, et al. (2005) Molecular Characterization of Adeno-Associated Viruses Infecting Children. J Virol 79: 14781-14792.
12. Gao G, Alvira MR, Somanathan S, Lu Y, Vandenberghe LH, et al. (2003) Adeno-associated viruses undergo substantial evolution in primates during natural infections. PNAS 100: 6081-6086.
13. Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, et al. (1999) Gene Therapy Vectors Based on Adeno-Associated Virus Type 1. J Virol 73: 3994-4003.
14. Bartosch B, Stefanidis D, Myers R, Weiss R, Patience C, et al. (2004) Evidence and consequence of porcine endogenous retrovirus recombination. J Virol 78: 13880-13890.
15. Yalkinoglu AO, Heilbronn R, Burkle A, Schlehofer JR, zur Hausen H (1988) DNA amplification of adeno-associated virus as a response to cellular genotoxic: stress. Cancer Res 48: 3123-3129.
16. Weitzman MD, Fisher KJ, Wilson JM (1996) Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J Virol 70: 1845-1851.
17. Raj K, Ogston P, Beard P (2001) Virus-mediated killing of cells that lack p53 activity. Nature 412: 914.
18. Yan Z, Zak R, Zhang Y, Engelhardt JF (2005) Inverted Terminal Repeat Sequences Are Important for Intermolecular Recombination and Circularization of Adeno-Associated Virus Genomes. J Virol 79: 361-379.
19. Zentilin L, Marcello A, Giacca M (2001) Involvement of Cellular Double-Stranded DNA Break Binding Proteins in Processing of the Recombinant Adeno-Associated Virus Genome. J Virol 75: 12279-12287.
20. Voigt CA, Martinez C, Wang ZG, Mayo SL, Arnold FH (2002) Protein building blocks preserved by recombination. Nat Struct Biol 9: 553-558.
21. Kohlbrenner E, Aslanidi G, Nash K, Shklyaev S, Campbell-Thompson M, et al. (2005) Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol Ther 12: 1217-1225.
22. de Souza SJ, Long M, Schoenbach L, Roy SW, Gilbert W (1996) Intron positions correlate with module boundaries in ancient proteins. Proc Natl Acad Sci U S A 93: 14632-14636.
23. Gilbert W, de Souza SJ, Long M (1997) Origin of genes. Proc Natl Acad Sci U S A 94: 7698-7703.
24. Erles K, Sebökovà P, Schlehofer J (1999) Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). Journal of Medical Virology 59: 406-411.
25. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
26. Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704.
27. Posada D, Crandall KA (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics, 14: 817-818.